The report, released March 23 by Nagoya University, is part of an ongoing fallout from a major scandal involving research at Japanese universities into the cardiovascular drug valsartan (Diovan).

Lowering your blood pressure reduces the chance of these disorders happening. Co-Diovan contains valsartan and hydrochlorothiazide. These medicines reduce blood pressure in two different ways.